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Background: We recently reported that in an experimental setting the zero pressure
level of solid intracranial pressure (ICP) sensors can be altered by electrostatics
discharges. Changes in the zero pressure level would alter the ICP level (mean ICP);
whether spontaneous changes in mean ICP happen in clinical settings is not known.
This can be addressed by comparing the ICP parameters level and waveform of
simultaneous ICP signals. To this end, we retrieved our recordings in patients with
cerebral bleeds wherein the ICP had been recorded simultaneously from two
different sensors. Materials and Methods: During a time period of 10 years, 17
patients with cerebral bleeds were monitored with two ICP sensors simultaneously;
sensor 1 was always a solid sensor while Sensor 2 was a solid -, a fluid - or an air-
pouch sensor. The simultaneous signals were analyzed with automatic identification
of the cardiac induced ICP waves. The output was determined in consecutive 6-s
time windows, both with regard to the static parameter mean ICP and the dynamic
parameters (mean wave amplitude, MWA, and mean wave rise time, MWRT).
Differences in mean ICP, MWA and MWRT between the two sensors were
determined. Transfer functions between the sensors were determined to evaluate
how sensors reproduce the ICP waveform.
Results: Comparing findings in two solid sensors disclosed major differences in
mean ICP in 2 of 5 patients (40%), despite marginal differences in MWA, MWRT, and
linear phase magnitude and phase. Qualitative assessment of trend plots of mean
ICP and MWA revealed shifts and drifts of mean ICP in the clinical setting. The
transfer function analysis comparing the solid sensor with either the fluid or air-
pouch sensors revealed more variable transfer function magnitude and greater
differences in the ICP waveform derived indices.
Conclusions: Simultaneous monitoring of ICP using two solid sensors may show
marked differences in static ICP but close to identity in dynamic ICP waveforms. This
indicates that shifts in ICP baseline pressure (sensor zero level) occur clinically; trend
plots of the ICP parameters also confirm this. Solid sensors are superior to fluid – and
air pouch sensors when evaluating the dynamic ICP parameters.© 2012 Eide et al.; licensee BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons
Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in
any medium, provided the original work is properly cited.
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Monitoring of the intracranial pressure (ICP) is crucial in the management of
neurosurgical patients [1–3]. The goal is then usually to keep the static pressure
parameter mean ICP or the dynamic pressure parameter mean ICP wave ampli-
tude (MWA) below certain threshold levels; i.e. the mean ICP <20-25 mmHg
[1,2], or the MWA <5 mmHg [3].
The ICP is most often measured using a solid sensor or through a fluid catheter
placed within a cerebral ventricle [4]. Though today’s practice of ICP monitoring
spans decades [5], newer data have shown that the level of the ICP (i.e. the static
ICP or the mean ICP) can be sensitive to inherent weaknesses in the sensors. We
hence recently reported that in an experimental setting spontaneous shifts in the
baseline pressure (sensor zero pressure) of a solid sensor can be triggered by elec-
trostatic discharges (ESDs) [6]. From this, one may ask if this also happens in
clinical settings, and whether the ICP scores that are presented on the monitoring
screen represent reality or not.
The questions raised above may be addressed by comparing simultaneous signals
obtained from two separate sensors placed intracranially in the same patient. To
this end, we retrieved our ICP recordings in all 17 patients with cerebral bleeds
wherein the ICP had been monitored simultaneously from two separate sensors.
We then compared the mean ICP (static pressure parameter) as well as the mean
wave amplitude (MWA) and mean wave rise time (MWRT) (dynamic pressure
parameters) of the two sensors. With special emphasis on the quality of the dy-
namic ICP signals, the transfer function of the sensor types used in the 17 patients
were also assessed.Methods
Patient recordings
The ICP recordings were retrieved from patients managed for aneurysmal subarach-
noid haemorrhage (SAH) and/or intra-cerebral haemorrhage (ICH) at the Department
of Neurosurgery, Oslo University Hospital – Rikshospitalet during the time period
2002–2011. Only patients wherein management included simultaneous monitoring
from two separate ICP sensors were included.
The Regional Committee for Medical and Health Research Ethics (REK) of Health
Region South-East, Norway was informed in writing, and had no objections to the
study. The study was approved by the Oslo University Hospital – Rikshospitalet as a
quality study.ICP monitoring and analysis
The setup for the simultaneous ICP monitoring was as follows: Sensor 1 was al-
ways a solid (strain-gauge) sensor (Codman Microsensor, Codman MicroSensor,
Johnson and Johnson, Raynham, Massachusetts, USA), while Sensor 2 was either
(a) another solid sensor (Codman Microsensor, Codman MicroSensor, Johnson and
Johnson, Raynham, Massachusetts, USA; Category A), (b) a fluid sensor (Edward’s
fluid sensor) connected to an external ventricular drain (Truwave PX-600 F Pres-
sure Monitoring Set, Edwards Life sciences LLC, Irvine, CA, USA; Category B), or (c)
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GE; Category C). Both ICP sensors were implanted at the same time.
The ICP sensors were introduced to the intracranial compartment either via a
small burr hole and a minimal opening in the dura or via the craniotomy used for
aneurysm clipping/hematoma evacuation. The solid sensor was placed within the
brain parenchyma, and connected via cable to the ICP Express (Codman ICP Ex-
press, Johnson and Johnson, Raynham, Massachusetts, USA). The fluid sensor was
connected outside the patient to an external ventricular drain (EVD) that had been
placed in the ventricular fluid, while the air-pouch sensor was placed inside the
brain parenchyma, and connected to a Spiegelberg ICP Monitor (Spiegelberg KG,
Hamburg, Ge). The ICP signals from all sensors were passed to a vital signs Sie-
mens 9000 XL Series Monitor (Siemens Medical Systems Inc., Danvers, MA, USA).
By means of the Siemens Infinity Gateway Software (Siemens Medical Systems
Inc., Danvers, MA, USA), the continuous ICP signals were transferred online via
the hospital network to a computer server and stored as raw data files (sampling
rate 100 Hz).
The analysis of the continuous ICP waveforms was done using a previously pub-
lished method for automatic cardiac induced ICP waves [7] that has been imple-
mented in the software (Sensometrics Software, dPCom As, Oslo). In short, the
process is as follows: (1) From the continuous pressure signal, each pressure wave
is identified by its beginning and ending diastolic minimum pressure, and its sys-
tolic maximum pressure. (2) For each pressure wave a set of single wave para-
meters is determined such as rise time (dT), amplitude (dP) and rise time
coefficient (RT). (3) Each pressure wave is differentiated as either a cardiac-beat-
induced ICP wave, or as an artefact-induced wave, depending on whether the sin-
gle wave parameters meet defined requirements. Thus, cardiac induced waves have
single wave parameters (e.g. dT, dP, RT) within defined threshold values 3) Then,
the identified cardiac-induced waves are applied for further analysis; analysis is
done during time windows of 6-s duration containing. Only 6-s time windows con-
taining minimum 4 cardiac beat induced waves were considered to be of good
quality, and were used for the present analysis. Thus, for each 6-s time window
the mean ICP and the ICP waveform indices mean wave amplitude (MWA) and
mean wave rise time (MWRT) were determined. For a 6-s time window to be
accepted according to the automatic method, it contained minimum four cardiac
induced waves. Accordingly, this method automatically differentiates between pres-
sure waves induced by the cardiac contractions and artefact waves due to noise in
the pressure signal (e.g. due to patient movement, or sensor movement or dysfunc-
tion); artefact waves were hence omitted from the analysis.
For this particular study, intracranial pressure recordings from the corresponding
6-s time windows containing simultaneous ICP signals and with identical time refer-
ences were then compared. A 6-s time window with two ICP signals (PatID 2) is
shown in Figure 1.
For each signal in every recording we determined the average values of mean
ICP, MWA and MWRT during the whole observation period as well as the per-
centage of 6-s time windows, with differences between signals of mean ICP
Figure 1 Simultaneous 6-s time windows of Signals 1 and 2 (PatID 2). A 6-s time window of the raw
signal of (a) Signal 1 and (b) Signal 2 of PatID 2, showing the cardiac-induced ICP waves. For every cardiac-
induced wave the amplitude (dP) and rise time (dT) were automatically determined (c). Mean ICP, mean ICP
wave amplitude (MWA) and rise time (MWRT) were determined for each 6-s time window; for the 6-s time
window shown in a-b, mean ICP was 21.3 mmHg (Signal 1) and 10.9 mmHg (Signal 2), MWA was
4.1 mmHg (Signal 1) and 4.1 mmHg (Signal 2), and MWRT was 0.21 sec (Signal 1) and 0.20 sec (Signal 2).
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>0.2 sec, respectively.Visual inspection of trend plots of mean ICP and MWA
For the 17 patient recordings, the trend plots of mean ICP and MWA for simultaneous
recordings were inspected for the occurrence of shifts or drifts of mean ICP relative to
MWA. This was done to qualitatively assess whether shifts in mean ICP occurred in
the clinical setting.Assessment of transfer function for the different types of sensors
The transfer function was estimated using the Matlab function tfestimate.m
(MathworksW, version R2011a with Signal Processing Toolbox version 6.15). It esti-
mates the linear filter required to transform the second transducer’s data (Signal 2)
into that of the reference transducer (Codman; Signal 1). The transfer function is
Figure 2 Transfer function of a 6-s time window of PatID 3. Analysis of one 6-s time window of PatID 3
showing (a) signals 1 (Codman) and 2 (dash-dot line, Codman), (b) transfer function of magnitude, and (c)
transfer function of phase with dash-dot line indicating estimate based on a delay of 0 sec. In this case,
15.6% of 6-s time windows showed a difference in MWA >1 mmHg (largest MWA in Signal 1 in 11.3% and
largest MWA in Signal 2 in 4.3%). In 0.5% of 6-s time windows, the difference in MWRT was >0.1 sec (largest
MWRT in Signal 1 in 0.2% and largest MWRT in Signal 2 in 0.3%).
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power spectral density (P11) of signal 1, T21(f ) = P21(f )/P11(f ). The transfer function
has a magnitude and a phase as indicated in Figures 2, 3,4 b and c. It has been
Figure 3 Transfer function of a 6-s time window of PatID 6. Analysis of one 6-s time window of PatID 6
showing (a) the signals 1(Codman) and 2 (dash-dot line, Edwards), (b) transfer function of magnitude, and
(c) transfer function of phase with dash-dot line indicating estimate based on a delay of 0.065 sec. In this
case, 47.1% of 6-s time windows showed a difference in MWA >1 mmHg (largest MWA in Signal 1 in 18.9%
and largest MWA in Signal 2 in 28.2%). In 12.8% of 6-s time windows, the difference in MWRT was >0.1 sec
(largest MWRT in Signal 1 in 12.7% and largest MWRT in Signal 2 in 0.1%).
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a minimum of 36 seconds (6 segments). Because the mean value was subtracted
for each time window, the transfer function analysis is not influenced by variations
Figure 4 Transfer function of a 6-s time window of PatID 15. Analysis of one 6-s time window of PatID
15 showing (a) signal 1 (Codman) and 2 (dash-dot line, Spiegelberg), (b) transfer function of magnitude,
and (c) transfer function of phase with dash-dot line indicating estimate based on a delay of 0.12 sec. In
this case, 80.4% of 6-s time windows showed a difference in MWA >1 mmHg (largest MWA in Signal 1 in
51.6% and largest MWA in Signal 2 in 28.8%). In 7.6% of 6-s time windows, the difference in MWRT was
>0.1 sec (largest MWRT in Signal 1 in 3.2% and largest MWRT in Signal 2 in 4.4%).
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according to φ = −2πfτ. It has been checked by estimating the delay in the time
domain. This can be done by inspecting the time plots (Figures 2,3 and 4a), but a
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(Matlab xcorr.m). The phase is a linear function which has been plotted with red
dotted lines on top of the transfer function phase. In all of the transfer-function
plots it matches very well with the estimated phase.Results
Patient recordings
Table 1 gives age, gender and type of bleed in the 17 patients included in the study,
while Table 2 shows type and location of the ICP sensors and number of accepted
(good quality) 6-s time windows containing two signals. For all patients combined, a
total of 441,654 6-s time windows were analyzed (Table 2).Comparisons of ICP parameters between simultaneous signals
Mean ICP
Table 3, left presents the mean ICP recorded by the two sensors. Differences in mean
ICP >5 mmHg in >20% of observations were seen in 2 of 5 patients (40%) when using
two solid sensors (Additional file 1: Category A; Table 3, right), in 4 of 5 patients (80%)
when using one solid and one fluid sensor (Additional file 2: Category B), and in 1of 7
patients (14%) when using one solid and one air-pouch sensor (Additional file 3:
Category C).Table 1 Demographic data of 17 patients with cerebral bleeds
PatID Age Gender Type of bleed
Category A
1 66 M SAH (ACOM)
2 76 M ICH (right parieto-occipital)
3 39 F SAH (ACOM)
4 72 F SAH (left MCA)
5 59 F SAH (left MCA)
Category B
6 56 M SAH (BA)
7 48 M SAH (left MCA)
8 60 M SAH (ACOM)
9 50 F SAH (right VA)
10 55 F SAH (ACOM)
Category C
11 66 M ICH (right frontal)/IVH
12 56 F SAH (right MCA)
13 60 F SAH (BA/left ICA)
14 54 M SAH (left PCOM)
15 67 M SAH (right PCOM)
16 71 M ICH (cerebellum)
17 82 F ICH (cerebellum)
ACOM: anterior communicating artery; BA: basilar artery; ICA: internal carotid artery;
ICH: Intra-cerebral haemorrhage; IVH: intra-ventricular haematoma; MCA: middle cerebral
artery; PCOM: posterior communicating artery; SAH: Subarachnoid haemorrhage;
VA: vertebral artery.
Table 2 Sensor type, sensor location and number of accepted simultaneous 6-s time
windows




Signal 1 Signal 2 Signal 1 Signal 2
Category A
1 Solid Solid Left frontal lobe Right frontal lobe 6,149
2 “ “ Left frontallobe Left occipital lobe 31,488
3 “ “ Right frontal lobe Right occipital lobe 8,208
4 “ “ Left frontal lobe Left frontal ventricular horn 21,435
5 “ “ Right frontal lobe Right frontal ventricular horn 19,703
Category B
6 Solid Fluid Right frontal lobe Right frontal ventricular horn 6,295
7 “ “ Right frontal lobe Right frontal ventricular horn 26,677
8 “ “ Right frontal lobe Right frontal ventricular horn 4,489
9 “ “ Right frontal lobe Right frontal ventricular horn 2,555
10 “ “ Left frontal lobe Left frontal ventricular horn 6,262
Category C
11 Solid Air-pouch Right frontal lobe Right frontal ventricular horn 44,445
12 “ “ Right frontal lobe Right frontal ventricular horn 93,506
13 “ “ Right frontal lobe Right frontal ventricular horn 52,137
14 “ “ Right frontal lobe Right frontal ventricular horn 37,192
15 “ “ Left frontal lobe Left frontal ventricular horn 38,274
16 “ “ Right frontal lobe Right frontal ventricular horn 588
17 “ “ Right frontal lobe Right frontal ventricular horn 42,251
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Table 4, gives the MWA recorded by the two sensors and percentage of simultaneous
6-s time windows where the MWA of the two sensors differed >1 mm Hg and >2 mm
Hg, respectively. Differences were marginal when using two solid sensors. (Additional
file 1: Category A). The patient with two solid sensors that had differences in >1 mmHg
in 16% of the 6-s time windows (PatID 3), were one out of two patients where one sen-
sor had been placed frontal and the other occipital. The other patient with such sensor
placements (PatID 2), presented with considerable differences in mean ICP but with
similar MWAs.
A difference in MWA >1 mmHg in more than 20% of the observations was seen in
4/5 (80%) of patients when using one solid and one fluid sensor (Additional file 2:
Category B), and in all 7 patients (100%) when using one solid and one air-pouch sen-
sor (Additional file 3: Category C; Table 4).
Mean ICP wave rise time (MWRT)
Table 5, presents MWRT as well as percentage of simultaneous 6-s time windows
where the MWRT of the two sensors differed >0.1 s and >0.2 s, respectively. Mar-
ginal differences in MWRT were seen when comparing two solid sensors were
seen (Category A). Also, when comparing one solid and one fluid sensor (Category B),
Table 3 Differences in mean ICP between simultaneous ICP signals
PatID Mean ICP (mmHg; average+ std) Percentage of 6-s time windows
with difference in mean ICP:
Signal 1 Signal 2 >5 mmHg >10 mmHg
Category A
1 5.3 + 2.7 8.1 + 2.3 2 -
2 9.2 + 2.9 18.1 + 3.6 100 50
3 9.3 + 3.7 9.5 + 3.0 11 2
4 8.1 + 2.9 2.7 + 2.3 68 -
5 9.1 + 2.3 5.8 + 2.5 - -
Category B
6 15.3 + 3.4 20.3 + 2.3 37 2
7 9.3 + 4.6 7.6 + 5.5 35 4
8 6.9 + 4.1 9.5 + 5.3 37 -
9 −0.48 + 2.4 −29.6 + 4.6 100 100
10 11.9 + 5.4 12.5 + 5.2 5 -
Category C
11 11.4 + 2.6 14.8 + 2.3 4 3
12 9.3 + 3.5 9.5 + 3.4 1 1
13 10.0 + 3.6 9.0 + 5.1 19 6
14 10.3 + 2.8 5.9 + 6.5 14 9
15 7.8 + 14.3 8.5 + 4.1 27 6
16 14.1 + 1.9 10.6 + 3.7 14 1
17 15.8 + 5.5 15.5 + 3.8 8 5
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differences were >0.1 s in more than 20% of observations in 3 of 7 patient recordings (43%;
Category C).
Examples of trend plots of mean ICPs and MWAs
Figures 5,6,7,8,9,10,11,12 and 13 show trend plots of mean ICPs and MWAs in 9 different
patients. Figures 5-8 are from Category A patients (PatID´s 1–4) and compared findings in
two solid sensors. The figures demonstrate shifts and drifts in mean ICP of both sensors,
but with different profiles of shifts between the two simultaneous signals. Figures 9-10 are
from Category B patients (PatID´s 9–10), comparing one solid and one fluid sensor. The
figures reveal shifts in mean ICP of the solid sensor, but with no accompanying shifts in
the fluid sensor. Finally, Figures 11-13 present findings in Category C Patients (PatID´s 11,
13 and 15), comparing one solid and one air pouch sensor. Shifts in mean ICP of the air-
pouch sensor were found in both PatID’s 12 and 13. In PatID 15 the shifts of mean ICP oc-
curred in opposite directions for the solid and the air-pouch sensor.
Impact of sensor characteristics on ICP waveform reproduction
While comparison of two solid sensors disclosed flat transfer function magnitude
(Figure 2b) and no phase delay (lower panel), Figure 2 (Figure 2c), comparing one solid
and one fluid sensor indicated some delay in the fluid sensor (Figure 3c). The delay was
even larger when comparing one solid and one air-pouch sensor (Figure 4c). In the
Table 4 Differences in mean wave amplitude (MWA) between simultaneous ICP signals
PatID MWA (mmHg; average+ std) Percentage of 6-s time windows
with difference in MWA:
Signal 1 Signal 2 >1 mmHg >2 mmHg
Category A
1 4.5 + 0.7 4.4 + 0.7 2 -
2 4.5 + 0.7 4.5 + 0.7 1 -
3 6.8 + 1.2 7.0 + 1.2 16 -
4 3.2 + 0.5 3.1 + 0.5 - -
5 1.9 + 0.8 1.6 + 0.6 - -
Category B
6 6.4 + 0.9 6.5 + 1.2 47 10
7 4.5 + 1.2 4.3 + 1.3 23 7
8 8.9 + 3.2 8.9 + 4.1 59 21
9 3.0 + 0.3 2.4 + 0.6 19 -
10 7.1 + 3.1 6.6 + 2.9 27 9
Category C
11 7.2 + 1.0 6.2 + 0.9 52 4
12 5.6 + 1.8 4.9 + 1.3 41 18
13 4.4 + 1.4 3.9 + 1.7 29 2
14 6.7 + 1.7 5.2 + 3.2 90 65
15 7.6 + 14.3 7.1 + 14.3 80 64
16 9.3 + 0.5 8.3 + 0.6 30 1
17 8.0 + 2.1 7.3 + 2.3 38 6
MWA: mean wave amplitude.
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nute (1.3 Hz), at which frequency the transfer function was positive (Figure 3b). The
phase was linear up to 5–6 Hz (Figure 3c). The positive gain at the frequency of the
heart beat is consistent with a larger estimate for the MWA for the Edwards sensor.
This was the case in the majority of the 6-second segments with different MWA-values.
Of the 47% of segments where the MWA values differed more than 1 mmHg, 28.2% of
all segments were for this case. When comparing one solid and one air-pouch sensor,
the transfer function falls off for frequencies above 60–120 heart beats per minute
(1–2 Hz) (Figure 4b). In this subject (PatID 15), the delay was linear in the same lim-
ited area. The heart rate was about 40 beats per minute (0.63 Hz), and the air pouch
sensor’s gain was about 2 dB below that of the solid sensor. This is consistent with the
statistical data for this subject since for the 80% of time windows where the MWA dif-
fered more than 1 mmHg, the majority (51.6% of all time windows) the MWA was lar-
ger for the Codman sensor. In this case the transfer function showed a clear low pass
character, but in other cases this was not the case and varied much more over the
interesting frequency interval up to 5–6 Hz.
Discussion
The main findings of the present study were that when comparing solid ICP sensors,
major differences in ICP level despite close to identical ICP waveform occurred in 2 of
5 (40%) of patients. Inspection of the trend plots of static and dynamic pressure
Table 5 Differences in mean wave rise time (MWRT) between simultaneous ICP signals
PatID MWRT (sec; average+ std) Percentage of 6-s time windows
with difference in MWRT:
Signal 1 Signal 2 >0.1 s >0.2 s
Category A
1 0.27 + 0.04 0.27 + 0.04 - -
2 0.21 + 0.02 0.21 + 0.02 - -
3 0.14 + 0.04 0.14 + 0.03 1 -
4 0.18 + 0.05 0.18 + 0.05 - -
5 0.28 + 0.06 0.28 + 0.05 - -
Category B
6 0.29 + 0.04 0.24 + 0.04 13 -
7 0.25 + 0.02 0.25 + 0.04 2 -
8 0.23 + 0.02 0.21 + 0.03 2 -
9 0.14 + 0.04 0.14 + 0.04 3 1
10 0.28 + 0.03 0.24 + 0.06 14 -
Category C
11 0.26 + 0.05 0.28 + 0.02 9 -
12 0.33 + 0.13 0.23 + 0.09 45 17
13 0.36 + 0.06 0.45 + 0.12 50 20
14 0.33 + 0.09 0.39 + 0.10 25 7
15 0.22 + 14.3 0.22 + 14.3 8 1
16 0.12 + 0.01 0.12 + 0.01 - -
17 0.24 + 0.05 0.25 + 0.03 7 -
MWRT: mean wave rise time.
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line pressure) occur clinically, most often in the solid sensors. The ICP waveform is
reproduced with variable quality by the fluid-filled and air pouch sensors.
The ICP sensors applied in this study are widely used. The solid Codman sensor [8–12]
was introduced in the 1980’s while the air-pouch Spiegelberg ICP sensor [13,14] has been
used since the 1990’s. The fluid Edward’s sensor has been used extensively in monitoring of
various fluid-pressures such as arterial blood pressure, intraventricular pressure and central
venous pressure. All of these technologies represent state-of-the art ICP monitoring.
ICP parameters of the study
Both static and dynamic intracranial pressure parameters were registered and data are
presented as average values for the whole observation period and as well as percentage
of differences between simultaneous 6-s time periods. When monitoring ICP as surveil-
lance of the critically ill patient, it is the score at a certain point of time or during a
shorter time period that guides patient management; here that corresponds to the 6-s
time periods. Though it can be disputed what may be regarded as major differences in
mean ICP, the present findings that the mean ICP differed >5 mm Hg in >20% of the
6-s time windows in 2 out of 5 patients when comparing findings in two solid sensors
and in 4 out of 5 patients when comparing scores from one solid and one fluid sensor
raises concerns. Since we compared only accepted 6-s time windows, the differences in
Figure 5 Trend plots of mean ICP/mean ICP wave amplitude of Signals 1 and 2 (PatID 1). The trend
plots of mean ICP and mean ICP wave amplitude (MWA) of (a) Signal 1 and (b) Signal 2 of PatID 1 is shown
[Average of mean ICP: 7.6 mmHg (Signal 1), 4.3 mmHg (Signal 2). Average of mean ICP wave amplitude:
4.1 mmHg (Signal 1), 4.0 mmHg (Signal 2)]. The vertical arrows indicate sudden changes in mean ICP
without accompanying changes in MWA; mean ICP changed differently for the two signals, being more
extensive for Signal 2.
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the clinical setting, usually the ICP level (mean ICP) is determined without considering
the quality of the ICP signal, i.e. whether the ICP signal contains cardiac induced ICP
waves or not. However, given the retrospective design of the study, we are unable to as-
sess to which degree patient management and patient outcome were influenced by the
differences in the two signals.
With regard to the MWA, the 6-s time window data were presented as percentage of
differences >1 or >2 mmHg, mm respectively. These thresholds were chosen as our ex-
perience suggests an upper normal threshold value in the MWA of 4–5 mmHg [3,15].
Accordingly, a difference in MWA >1 mmHg could have impact on patientFigure 6 Trend plots of mean ICP/mean ICP wave amplitude of Signals 1 and 2 (PatID 2). The trend
plots of mean ICP and mean ICP wave amplitude (MWA) of (a) Signal 1 and (b) Signal 2 of PatID 2 is shown
[Average of mean ICP: 8.4 mmHg (Signal 1), 15.2 mmHg (Signal 2). Average of mean ICP wave amplitude:
4.8 mmHg (Signal 1), 4.8 mmHg (Signal 2)]. The vertical arrow in (a) indicates a drift in mean ICP without
accompanying change in MWA. While mean ICP drifted in (a), no such simultaneous change in mean ICP in
(b) was seen.
Figure 7 Trend plots of mean ICP/mean ICP wave amplitude of Signals 1 and 2 (PatID 3). The trend
plots of mean ICP and mean ICP wave amplitude (MWA) of (a) Signal 1 and (b) Signal 2 of PatID 3 is shown
[Average of mean ICP: 3.2 mmHg (Signal 1), 11.3 mmHg (Signal 2). Average of mean ICP wave amplitude:
6.1 mmHg (Signal 1), 6.4 mmHg (Signal 2)]. The vertical arrow in (b) indicates a shift in mean ICP without
accompanying changes in MWA; no accompanying change in mean ICP in (a) was seen.
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solid - and the fluid sensor, and particularly between the solid - and the air-pouch sensors
(Table 5). When the MWRT was shorter for the fluid sensors this is probably related to the
fact that EVDs may be kept open during monitoring, giving shortened MWRT. For the air-
pouch sensor, it is related to the transfer function with variable phase.
The combination of findings when comparing scores from two solid sensors with
considerable difference in mean ICP but close to identity in the MWAs, are very simi-
lar to results we have previously obtained using two solid sensors when monitoring
neurosurgical patients [16,17], and thus should reflect reality. Others also previouslyFigure 8 Trend plots of mean ICP/mean ICP wave amplitude of Signals 1 and 2 (PatID 4). The trend
plots of mean ICP and mean ICP wave amplitude (MWA) of (a) Signal 1 and (b) Signal 2 of PatID 4 is shown
[Average of mean ICP: 8.6 mmHg (Signal 1), 1.5 mmHg (Signal 2). Average of mean ICP wave amplitude:
3.3 mmHg (Signal 1), 3.2 mmHg (Signal 2)]. The vertical arrows in (a) and (b) indicate shifts in mean ICP
without accompanying changes in MWA; mean ICP shifted differently for the two signals, being more
extensive for Signal 1.
Figure 9 Trend plots of mean ICP/mean ICP wave amplitude of Signals 1 and 2 (PatID 6). The trend
plots of mean ICP and mean ICP wave amplitude (MWA) of (a) Signal 1 and (b) Signal 2 of PatID 6 is shown
[Average of mean ICP: 15.7 mmHg (Signal 1), 19.5 mmHg (Signal 2). Average of mean ICP wave amplitude:
6.7 mmHg (Signal 1), 6.7 mmHg (Signal 2)]. The vertical arrow in (a) indicates a shift in mean ICP without
accompanying change in MWA. The shift of mean ICP in (a) was not accompanied by a simultaneous shift
in mean ICP in (b).
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though the ICP waveforms were not compared [10].Properties of the ICP sensors
With regard to the quality of the ICP signal, focus has previously been on the long-
term-drift of the sensors, their sensitivity to temperature changes, and sensor accuracy
comparisons [18–21]. In contrast, the literature has been scarce on specifications of the
ICP sensors. Czosnyka et al. [18] reported that the Codman frequency response goes to
more than 30 Hz (slew rate −2200 mm Hg/s), and Piper and Miller [8] indicated anFigure 10 Trend plots of mean ICP/mean ICP wave amplitude of Signals 1 and 2 (PatID 7). The trend
plots of mean ICP and mean ICP wave amplitude (MWA) of (a) Signal 1 and (b) Signal 2 of PatID 7 is shown
[Average of mean ICP: 16.3 mmHg (Signal 1), 6.4 mmHg (Signal 2). Average of mean ICP wave amplitude:
4.5 mmHg (Signal 1), 4.2 mmHg (Signal 2)]. The vertical arrows in (a) indicate shifts in mean ICP without
accompanying changes in MWA. The shifts of mean ICP in (a) were not accompanied by simultaneous
shifts in mean ICP in (b).
Figure 11 Trend plots of mean ICP/mean ICP wave amplitude of Signals 1 and 2 (PatID 12). The
trend plots of mean ICP and mean ICP wave amplitude (MWA) of (a) Signal 1 and (b) Signal 2 of PatID 12 is
shown [Average of mean ICP: 6.8 mmHg (Signal 1), 11.9 mmHg (Signal 2). Average of mean ICP wave
amplitude: 5.6 mmHg (Signal 1), 5.7 mmHg (Signal 2)]. The vertical arrow in (b) indicates a shift in mean ICP
without accompanying change in MWA. The shift of mean ICP in (b) was not accompanied by a
simultaneous shift in mean ICP in (a).
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anticipated in the ICP signal and should provide for good waveform reproduction.
According to the manufacturers, the frequency response of the fluid Edward’s sensor is
40 Hz (response goes to > 200 Hz for the transducer alone). With regard to the air-
pouch Spiegelberg sensor, its cut-off was reported by Czosnyka et al. [22] to be 4–5 Hz.
We presently found it to be even lower (1–2 Hz).
The time-domain method depends on as exact as possible reproduction of the time
domain waveform for measuring peak values, peak excursions and latencies. This
means that the transfer function between different sensors should be flat in the mostFigure 12 Trend plots of mean ICP/mean ICP wave amplitude of Signals 1 and 2 (PatID 13). The
trend plots of mean ICP and mean ICP wave amplitude (MWA) of (a) Signal 1 and (b) Signal 2 of PatID 13 is
shown [Average of mean ICP: 9.8 mmHg (Signal 1), 5.0 mmHg (Signal 2). Average of mean ICP wave
amplitude: 3.4 mmHg (Signal 1), 2.5 mmHg (Signal 2)]. The vertical arrow in (b) indicates a shift in mean ICP
without accompanying change in MWA. The shift of mean ICP in (b) was not accompanied by a
simultaneous shift of mean ICP in (a).
Figure 13 Trend plots of mean ICP/mean ICP wave amplitude of Signals 1 and 2 (PatID 15). The
trend plots of mean ICP and mean ICP wave amplitude (MWA) of (a) Signal 1 and (b) Signal 2 of PatID 15 is
shown [Average of mean ICP: -1.3 mmHg (Signal 1), 7.2 mmHg (Signal 2). Average of mean ICP wave
amplitude: 8.7 mmHg (Signal 1), 5.5 mmHg (Signal 2)]. The vertical arrows in (a) and (b) indicate shifts in
mean ICP; no apparent lasting changes in MWA were seen. The shifts of mean ICP in (a) and (b) were in
opposite directions.
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possible. The present comparisons between sensors showed that the phase was linear
over the most important frequency range which is a good feature. With regard to the
magnitude of the transfer function, it corresponded poorly with the only past statement
about the frequency response of the air pouch Spiegelberg sensor known [22]. Based
on our analysis, we conclude that the transfer function between the solid Codman sen-
sor and either the fluid Edwards sensor or the air pouch Spiegelberg sensor is quite
variable, affecting both the MWA and the MWRT measures. The variation in MWA
and MWRT estimates must be caused by variability in the fluid Edward´s and air-
pouch Spiegelberg sensors. This may result in either higher or lower values for both
the MWAs and MWRTs of these sensors when compared to the reference solid
Codman sensor.
Impact of hospital environment on ICP scores
There are three major factors related to hospital environment that may affect the ICP
scores: Human factors, technical issues and technology issues.
Among the human factors, erroneous zeroing of the ICP sensor is of paramount im-
portance. Some solid sensors, such as the Codman and the Camino, can be zeroed only
prior to implantation. The Spiegelberg sensor is the only ICP sensor that performs
in vivo zeroing, while the Raumedic sensor performs post-implantation electrical zero-
ing, though not a true in-vivo (atmospheric pressure) check of the catheter-tip sensor.
Using a fluid sensor, the zero pressure level depends on the selected zero point relative
to the head or the heart; furthermore, with regard to the head there is no consensus
whether the zero point should be at the level of the tragus, the eye, vertex, or the
frontal bone.
Several technical issues are involved. Sensor damage may occur at any point of time.
The sensor may further respond to electrostatic discharges (ESD’s) [6]. Using a fluid
system, the sensor is placed at some distance from the patient, requiring that a fluid
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lar fluid) and the sensor site. Air bubbles and/or partial/total occlusion of the fluid
catheter by blood cloths or brain tissue allows for erroneous pressure reproduction.
Mal-positioning of the catheter (outside of the brain fluid) may also give erroneous
pressure readings. The physical properties - and the length of the fluid-filled catheter
as well as sensor location relative to the patient also influence pressure readings.
Technology issues relate to the properties of the ICP sensor itself. Presently, we
showed that the transfer function varied between solid and fluid/air pouch sensors, in
particular, the technology of the air pouch sensor made this sensor type less useful for
reproduction of pressure waveforms. The Spiegelberg sensor presently used utilizes an
air pouch system that lacks the frequency characteristics needed for proper waveform
reproductions. On the other hand, the ability of the Spiegelberg sensor to perform true
post-implantation zeroing might be one explanation of the relatively smaller differences
in mean ICP we observed when using this sensor.
Both human errors and technical issues may affect the static pressure parameter
mean ICP. This is related to the current approach of determining the mean ICP as an
absolute value relative to the atmospheric pressure (usually referred to as baseline pres-
sure, reference pressure, or zero pressure level). Accordingly, the ICP sensors are zer-
oed against the atmospheric pressure, and the mean ICP that is revealed on the screen
is a pressure value relative to the atmospheric pressure. The present data show
that baseline pressure shifts and drifts in deed represent a clinical issue (Table 3;
Figure 5-13). The spontaneous sudden shifts in mean ICP thus resemble those we
have previously seen in an experimental setting where the ESD’s impact the zero
pressure level of ICP sensors were extensive [6]. They are also similar to those
and may explain plain the sudden shifts in the mean ICP that can occur during
long-term monitoring within the intensive care unit (ICU) [23].Quality control during ICP monitoring
Managing patients according to erroneous ICP scores could be fatal; thus the issue of
quality control during ICP monitoring is important. Today’s quality control is usually
as follows: In situations where an external drain had been placed for CSF drainage, the
static intracranial pressure (mean ICP) can be “semi-quantitatively” assessed by measur-
ing the height of the fluid in the fluid-filled catheter. Also, in patients treated with
decompressive craniectomy, the ICP may be crudely evaluated by slight compression at
the craniectomy site. Quality assessment of the pressure waveform is done by visual in-
spection of the ICP waveform on the screen of the vital signs monitor or by inspection
of the fluid pulsations within a fluid-filled catheter of a CSF drain. However, as men-
tioned above even partial occlusion of a CSF drain may give erroneous dynamic pres-
sure reproductions. Also, qualitative assessment of the pressure waveform provides
minimal information whether the waveform is normal or not.
A quality control beyond what is mentioned above can be obtained by the use of
computer software that in an intelligent manner identifies “noise” in the ICP signal,
and also automatically identifies the cardiac induced ICP waves [7]. Increasing propor-
tion of “noisy” waves indicates poor signal quality. In such a setting, the sensor system
would need the proper ability to retrieve the ICP waveform. Incorporating ICP
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static ICP scores [16,17,24]. Based on how the static mean ICP and the dynamic MWA
relates, finding of a pathological high mean ICP together with a normal (low) MWA
indicates an erroneous static ICP. From this, monitoring the dynamic intracranial pres-
sure parameters ought to be the primary type of intracranial pressure monitoring. Pres-
ently, the solid Codman sensor was superior for measuring ICP waveforms when
compared with that of the fluid Edward’s sensor and particularly the air-pouch
Spiegelberg sensor.Conclusions
Simultaneous monitoring of ICP using two solid sensors may show marked differences
in static ICP (mean ICP or ICP level) but close to identity in dynamic ICP waveforms.
This indicates that shifts in ICP baseline pressure (sensor zero level) occur during ICP
monitoring. Trend plots of the ICP parameters confirm that shift in mean ICP (due to
spontaneously changed ICP baseline pressure) in deed occur clinically. Solid sensors
are superior to fluid – and air pouch sensors when evaluating the dynamic ICP
parameters.
Additional files
Additional file 1: Category A. Animation of measurements of Signals 1 and 2 in PatID 2. The animation shows
the simultaneous continuous ICP waveform of Signals 1 (Codman; lower signal) and 2 (Codman; upper signal) in
PatID 2. Note that the ICP waveform is identical while the baseline pressure is different.
Additional file 2: Category B. Animation of measurements of Signals 1 and 2 in PatID 8. The animation shows
the simultaneous continuous ICP waveform of Signals 1 (Codman; lower signal) and 2 (Edwards; upper signal) in
PatID 8. Note that the ICP waveform is quite similar while the baseline pressure is different.
Additional file 3: Category C. Animation of measurements of Signals 1 and 2 in PatID 11. The animation shows
the simultaneous continuous ICP waveform of Signals 1 (Codman; lower signal) and 2 (Spiegelberg; upper signal)
in PatID 11. Note that both the ICP waveform and the baseline pressure are different.
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